nach oben

Erschienen in:

01.12.2008 | Original Paper

Polymorphisms of the NER pathway genes, ERCC1 and XPD are associated with esophageal adenocarcinoma risk

verfasst von: Darren Tse, Rihong Zhai, Wei Zhou, Rebecca S. Heist, Kofi Asomaning, Li Su, Thomas J. Lynch, John C. Wain, David C. Christiani, Geoffrey Liu

Erschienen in: Cancer Causes & Control | Ausgabe 10/2008

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Functional variation in DNA repair capacity through single nucleotide polymorphisms (SNPs) of key repair genes is associated with a higher risk of developing various types of cancer. Studies have focused on the nucleotide excision repair (NER) and base excision repair (BER) pathways. We investigated whether variant alleles in seven SNPs within these pathways increased the risk of esophageal adenocarcinoma.

Methods

DNA was extracted from prospectively collected blood specimens. The samples were genotyped for SNPs in NER genes (XPD Lys751Gln, XPD Asp312Asn, ERCC1 8092C/A, and ERCC1 118C/T), and BER genes (XRCC1 Arg399Gln, APE1 Asp148Glu, and hOGG1 Ser326Cys). The presence of variant alleles was correlated with risk of esophageal adenocarcinoma both individually and jointly.

Results

Variant alleles in NER SNPs XPD Lys751Gln (AOR = 1.50, 95% CI 1.1–2.0), ERCC1 8092 C/A (AOR = 1.44, 95% CI 1.1–1.9), and ERCC1 118C/T (AOR = 1.42, 95% CI 1.0–1.9) were individually associated with esophageal adenocarcinoma risk. An increasing number of variant alleles in NER SNPs showed a significant trend with esophageal adenocarcinoma risk (p = 0.007).

Conclusions

The presence of variant alleles in NER genes increases risk of esophageal adenocarcinoma. There is evidence of an additive role for SNPs along a common DNA repair pathway. Future larger studies of esophageal adenocarcinoma etiology should evaluate entire biological pathways.

Devesa SS, Blot WJ, Fraumeni JF Jr (1998) Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83(10):2049–2053PubMedCrossRef

Younes M, Henson DE, Ertan A, Miller CC (2002) Incidence and survival trends of esophageal carcinoma in the United States: racial and gender differences by histological type. Scand J Gastroenterol 37(12):1359–1365PubMedCrossRef

Ilson DH (2003) Oesophageal cancer: new developments in systemic therapy. Cancer Treat Rev 29(6):525–532PubMedCrossRef

Holmes RS, Vaughan TL (2007) Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol 17(1):2–9PubMedCrossRef

Siewert JR, Ott K (2007) Are squamous and adenocarcinomas of the esophagus the same disease? Semin Radiat Oncol 17(1):38–44PubMedCrossRef

Cameron AJ (1997) Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol Clin North Am 26(3):487–494PubMedCrossRef

Casson AG, Zheng Z, Evans SC, Veugelers PJ, Porter GA, Guernsey DL (2005) Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma. Carcinogenesis 26(9):1536–1541PubMedCrossRef

Drewitz DJ, Sampliner RE, Garewal HS (1997) The incidence of adenocarcinoma in Barrett’s esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 92(2):212–215PubMed

Katzka DA, Rustgi AK (2000) Gastroesophageal reflux disease and Barrett’s esophagus. Med Clin North Am 84(5):1137–1161PubMedCrossRef

10.

Naidoo R, Chetty R (1999) DNA repair gene status in oesophageal cancer. Mol Pathol 52(3):125–130PubMedCrossRef

11.

Sharma P, Morales TG, Bhattacharyya A, Garewal HS, Sampliner RE (1997) Dysplasia in short-segment Barrett’s esophagus: a prospective 3-year follow-up. Am J Gastroenterol 92(11):2012–2016PubMed

12.

Lee JM, Lee YC, Yang SY et al (2001) Genetic polymorphisms of XRCC1 and risk of the esophageal cancer. Int J Cancer 95(4):240–246PubMedCrossRef

13.

Benhamou S, Tuimala J, Bouchardy C, Dayer P, Sarasin A, Hirvonen A (2004) DNA repair gene XRCC2 and XRCC3 polymorphisms and susceptibility to cancers of the upper aerodigestive tract. Int J Cancer 112(5):901–904PubMedCrossRef

14.

Hu JJ, Hall MC, Grossman L et al (2004) Deficient nucleotide excision repair capacity enhances human prostate cancer risk. Cancer Res 64(3):1197–1201PubMedCrossRef

15.

Li C, Hu Z, Liu Z et al (2006) Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case–control analysis. Cancer Epidemiol Biomarkers Prev 15(12):2526–2532PubMedCrossRef

16.

Lunn RM, Helzlsouer KJ, Parshad R et al (2000) XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis 21(4):551–555PubMedCrossRef

17.

Ramos JM, Ruiz A, Colen R, Lopez ID, Grossman L, Matta JL (2004) DNA repair and breast carcinoma susceptibility in women. Cancer 100(7):1352–1357PubMedCrossRef

18.

Shen H, Spitz MR, Qiao Y et al (2003) Smoking, DNA repair capacity and risk of nonsmall cell lung cancer. Int J Cancer 107(1):84–88PubMedCrossRef

19.

Shi Q, Wang LE, Bondy ML, Brewster A, Singletary SE, Wei Q (2004) Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients. Carcinogenesis 25(9):1695–1700PubMedCrossRef

20.

Spitz MR, Wu X, Wang Y et al (2001) Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res 61(4):1354–1357PubMed

21.

Wei Q, Cheng L, Amos CI et al (2000) Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst 92(21):1764–1772PubMedCrossRef

22.

Wei Q, Lee JE, Gershenwald JE et al (2003) Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma. J Natl Cancer Inst 95(4):308–315PubMedCrossRef

23.

Duell EJ, Wiencke JK, Cheng TJ et al (2000) Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis 21(5):965–971PubMedCrossRef

24.

Wang Y, Spitz MR, Zhu Y, Dong Q, Shete S, Wu X (2003) From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair (Amst) 2(8):901–908CrossRef

25.

Benhamou S, Sarasin A (2005) ERCC2/XPD gene polymorphisms and lung cancer: a HuGE review. Am J Epidemiol 161(1):1–14PubMedCrossRef

26.

Ye W, Kumar R, Bacova G, Lagergren J, Hemminki K, Nyren O (2006) The XPD 751Gln allele is associated with an increased risk for esophageal adenocarcinoma: a population-based case–control study in Sweden. Carcinogenesis 27(9):1835–1841PubMedCrossRef

27.

Liu G, Zhou W, Yeap BY et al (2007) XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk. Carcinogenesis 28(6):1254–1258PubMedCrossRef

28.

Goode EL, Ulrich CM, Potter JD (2002) Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11(12):1513–1530PubMed

29.

Hao B, Wang H, Zhou K et al (2004) Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma. Cancer Res 64(12):4378–4384PubMedCrossRef

30.

Weiss JM, Goode EL, Ladiges WC, Ulrich CM (2005) Polymorphic variation in hOGG1 and risk of cancer: a review of the functional and epidemiologic literature. Mol Carcinog 42(3):127–141PubMedCrossRef

31.

Xing D, Qi J, Miao X, Lu W, Tan W, Lin D (2002) Polymorphisms of DNA repair genes XRCC1 and XPD and their associations with risk of esophageal squamous cell carcinoma in a Chinese population. Int J Cancer 100(5):600–605PubMedCrossRef

32.

Xing DY, Tan W, Song N, Lin DX (2001) Ser326Cys polymorphism in hOGG1 gene and risk of esophageal cancer in a Chinese population. Int J Cancer 95(3):140–143PubMedCrossRef

33.

Chen S, Tang D, Xue K et al (2002) DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population. Carcinogenesis 23(8):1321–1325PubMedCrossRef

34.

Hu Z, Wang Y, Wang X et al (2005) DNA repair gene XPC genotypes/haplotypes and risk of lung cancer in a Chinese population. Int J Cancer 115(3):478–483PubMedCrossRef

35.

Hu Z, Xu L, Shao M et al (2006) Polymorphisms in the two helicases ERCC2/XPD and ERCC3/XPB of the transcription factor IIH complex and risk of lung cancer: a case–control analysis in a Chinese population. Cancer Epidemiol Biomarkers Prev 15(7):1336–1340PubMedCrossRef

36.

Chacko P, Rajan B, Joseph T, Mathew BS, Pillai MR (2005) Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer. Breast Cancer Res Treat 89(1):15–21PubMedCrossRef

37.

Benhamou S, Sarasin A (2002) ERCC2/XPD gene polymorphisms and cancer risk. Mutagenesis 17(6):463–469PubMedCrossRef

38.

Lee KM, Choi JY, Kang C et al (2005) Genetic polymorphisms of selected DNA repair genes, estrogen and progesterone receptor status, and breast cancer risk. Clin Cancer Res 11(12):4620–4626PubMedCrossRef

39.

Shen J, Desai M, Agrawal M et al (2006) Polymorphisms in nucleotide excision repair genes and DNA repair capacity phenotype in sisters discordant for breast cancer. Cancer Epidemiol Biomarkers Prev 15(9):1614–1619PubMedCrossRef

40.

Chen P, Wiencke J, Aldape K et al (2000) Association of an ERCC1 polymorphism with adult-onset glioma. Cancer Epidemiol Biomarkers Prev 9(8):843–847PubMed

41.

Zhou W, Liu G, Park S et al (2005) Gene–smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer. Cancer Epidemiol Biomarkers Prev 14(2):491–496PubMedCrossRef

42.

Park DJ, Zhang W, Stoehlmacher J et al (2003) ERCC1 gene polymorphism as a predictor for clinical outcome in advanced colorectal cancer patients treated with platinum-based chemotherapy. Clin Adv Hematol Oncol 1(3):162–166PubMed

43.

Viguier J, Boige V, Miquel C et al (2005) ERCC1 codon 118 polymorphism is a predictive factor for the tumor response to oxaliplatin/5-fluorouracil combination chemotherapy in patients with advanced colorectal cancer. Clin Cancer Res 11(17):6212–6217PubMedCrossRef

44.

Suk R, Gurubhagavatula S, Park S et al (2005) Polymorphisms in ERCC1 and grade 3 or 4 toxicity in non-small cell lung cancer patients. Clin Cancer Res 11(4):1534–1538PubMedCrossRef

45.

Zhou W, Gurubhagavatula S, Liu G et al (2004) Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. Clin Cancer Res 10(15):4939–4943PubMedCrossRef

Titel: Polymorphisms of the NER pathway genes, ERCC1 and XPD are associated with esophageal adenocarcinoma risk
verfasst von: Darren Tse
Rihong Zhai
Wei Zhou
Rebecca S. Heist
Kofi Asomaning
Li Su
Thomas J. Lynch
John C. Wain
David C. Christiani
Geoffrey Liu
Publikationsdatum: 01.12.2008
Verlag: Springer Netherlands
Erschienen in: Cancer Causes & Control / Ausgabe 10/2008
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-008-9171-4

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Polymorphisms of the NER pathway genes, ERCC1 and XPD are associated with esophageal adenocarcinoma risk